Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type II cytoskeletal 72 (KRT72) is a member of the type II keratin family of intermediate filament cytoskeletal proteins, specifically expressed in the inner root sheath of hair follicles, where it contributes to hair structure and formation [2][3][5]. KRT72 forms part of the cytoskeletal network that provides mechanical strength to epithelial cells and plays a critical role in the differentiation of keratinizing cells during hair development [2]. Recent research also suggests KRT72 participates in antiviral defense by binding and sequestering incoming HIV-1 capsids in the cytoplasm of resting CD4+ T cells, impeding viral trafficking and infection at a postentry stage [1]. There is currently no documentation of KRT72 acting as a therapeutic target, receptor, enzyme, transporter, or biomarker in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type II cytoskeletal 72 (KRT72).